The primary aim of this study was to examine central fatigue of the plantar flexor muscle group after prolonged running using the twitch interpolation technique. Eight healthy, habitually active male subjects ran on a motorized treadmill for 2 h at a speed corresponding to 75% of peak oxygen uptake (VO(2peak)). Maximal voluntary isometric contraction (MVC) strength as well as the electrically induced twitch produced during MVC [interpolated twitch (IT)] and at rest [resting twitch (RT)] were measured before and after running. The level of activation (LOA) during each MVC was calculated as LOA (%)=100(1-IT/RT). Both MVC and LOA decreased (17+/-16% and 19+/-15%, respectively, P<0.05) after running, whereas RT did not change. The decrease in MVC was correlated with the decrease in LOA (r=0.87, P<0.05). The results demonstrate that after 2 h of treadmill running at an intensity of 75% of VO(2peak), there was a reduction in maximal voluntary plantar flexor muscle strength that was mainly related to central fatigue.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1600-0838.2007.00721.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Eosinophilic granulomatosis with polyangiitis; a distinctive presentation with myocarditis and autoimmune haemolytic anaemia: case report.
Front Cardiovasc Med
January 2025
Family and Community Medicine Department, Faculty of Medicine, Jazan University, Jazan, Saudi Arabia.
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is an extremely rare type of vasculitis characterized by inflammation within small blood vessels or tissues that may cause damage to the lungs, heart, kidneys, and other organs. Here, we present a rare case of EGPA with cardiac involvement that presented with acute heart failure.
Clinical Findings: A 44-year-old woman with a history of bronchial asthma and sinusitis presented with fever, shortness of breath, fatigue, unintentional weight loss, and polyarthritis.
Association of chronic low back pain and knee pain with subjective fatigue incidence among community-dwelling older adults: A prospective cohort study.
Geriatr Gerontol Int
January 2025
Department of Preventive Gerontology, Center for Gerontology and Social Science, Research Institute, National Center for Geriatrics and Gerontology, Obu, Japan.
Aim: Fatigue is a common health problem in older adults. Chronic pain is associated with fatigue. However, the longitudinal association between chronic pain and the incidence of subjective fatigue among community-dwelling older adults remains unclear.
View Article and Find Full Text PDFEffects of β-glucans on fatigue: a systematic review and meta-analysis.
Eur J Clin Nutr
January 2025
Department of Clinical and Translational Research Methodology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Several clinical trials suggest that β-glucans may reduce feelings of fatigue, however the results of clinical trials are inconsistent. Additionally, no systematic reviews or meta-analyses have assessed the effects of β-glucans on fatigue. Therefore, this study investigates the effects of β-glucans on fatigue in healthy subjects through a systematic review and meta-analysis.
View Article and Find Full Text PDFThe number of central nervous system-driven symptoms predicts subsequent chronic primary pain: evidence from UK Biobank.
Br J Anaesth
January 2025
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Department of Rheumatology, Mayo Clinic, Jacksonville, FL, USA.
Background: Chronic primary pain describes conditions where pain is the principal problem rather than a consequence of another disease. Primary pain is thought to be primarily owing to nociplastic pain (i.e.
View Article and Find Full Text PDFRoxadustat-Induced Central Hypothyroidism Masked by Uremia at the Initiation of Hemodialysis: A Case Report.
Cureus
December 2024
Nephrology, Yokohama Municipal Citizen's Hospital, Yokohama, JPN.
Hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) is a novel class of orally administered medications for renal anemia in patients with end-stage renal disease (ESRD). Roxadustat, a HIF-PHI, has a structure similar to that of triiodothyronine and may work as an agonist for thyroid hormone receptor-beta in the pituitary gland and/or hypothalamus. Therefore, roxadustat may cause central hypothyroidism due to suppressing thyroid-stimulating hormone (TSH) release in the pituitary gland and/or thyrotropin-releasing hormone release in the hypothalamus.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!